Skip to main content
. 2017 Jun 20;12(6):e0179857. doi: 10.1371/journal.pone.0179857

Table 3. Risks of dementia and AD after a cancer diagnosis among ACT study participants.

This table shows follow-up time, dementia and AD incidence, and crude and unadjusted risks of dementia and AD for prevalent and incident cancers. Abbreviations include: ACT (Adult Changes in Thought); AD (Alzheimer’s disease); CI (confidence interval); and HR (hazard ratio).

Dementia follow-up time(person-years) # events Incidence per 1000 person years 95% CI Crude HR1 95% CI Adjusted HR2 95%CI
No cancer 26,735 839 31.4 29.3, 33.6 1 1
Prevalent cancer 4,872 154 31.6 27.0, 37.0 0.93 0.78, 1.10 0.92 0.76, 1.11
Incident cancer 2,874 98 34.1 28.0, 41.6 0.82 0.66, 1.01 0.82 0.64, 1.04
Possible/Probable AD
No cancer 26,735 678 25.4 23.5, 27.3 1 1
Prevalent cancer 4,872 126 25.8 21.7, 30.8 0.93 0.77, 1.13 0.95 0.77, 1.17
Incident cancer 2,874 73 25.4 20.2, 31.9 0.73 0.58, 0.94 0.73 0.55, 0.96

1Crude HR uses age as the time scale

2Additionally adjusted for age at ACT study entry, ACT cohort, gender, education, diabetes, hypertension, heart disease, stroke, smoking status, low self-rated health, regular exercise, and body mass index